Skip to content
  • Sunday, 26 July 2026
  • 12:46 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Blazar Populations Identified as Likely Source of Record-Breaking 220 PeV Neutrino Detected by KM3NeT/ARCA
Advanced Materials Science

Blazar Populations Identified as Likely Source of Record-Breaking 220 PeV Neutrino Detected by KM3NeT/ARCA

Nila Kartika Wati Jun 1, 2026 0

The field of high-energy astrophysics has been fundamentally altered by the detection of a single subatomic particle that traversed the…

Read More
Advanced Materials Science

Record-Breaking 220 PeV Cosmic Neutrino Detection Points to Blazars as Supreme Galactic Accelerators

Nila Kartika Wati May 24, 2026 0

On February 13, 2023, an instrument located more than 3,000 meters beneath the surface of the Mediterranean Sea registered a…

Read More
Advanced Materials Science

Exploding Primordial Black Holes and the Mystery of the Ultra-High-Energy Neutrino: A New Frontier in Particle Physics

Nila Kartika Wati May 1, 2026 0

In the vast, silent expanse of the cosmos, particles of nearly inconceivable energy occasionally strike the Earth’s atmosphere, leaving scientists…

Read More
Advanced Materials Science

Decoding the Cosmic Mystery of the Ultra High Energy Neutrino Through the Lens of Quasi Extremal Primordial Black Holes

Nila Kartika Wati Apr 24, 2026 0

In the autumn of 2023, the scientific community was sent into a state of high alert when a subatomic particle…

Read More
Advanced Materials Science

Exploding Primordial Black Holes and the Mystery of the Ultra-High-Energy Neutrino: A New Frontier in Particle Astrophysics

Nila Kartika Wati Apr 16, 2026 0

In the vast, silent expanse of the cosmos, particles of nearly unimaginable energy occasionally streak toward Earth, carrying secrets from…

Read More
Advanced Materials Science

Indiana University Researchers Unveil Breakthrough in Cosmic Matter Mystery Through Global Neutrino Collaboration

Nila Kartika Wati Mar 23, 2026 0

In a landmark achievement for the field of particle physics, researchers at Indiana University (IU) have contributed to a significant…

Read More
Daiichi Sankyo and Tempus AI collaborate on ADC clinical developmentBoehringer Ingelheim eyes MASH as the next front for survodutide, a GLP-1/glucagon receptor dual agonistSai Life Sciences’ Biotech Pitch Day 2026 Unveils Groundbreaking Innovations from Early-Stage Biotechs, Reinforcing Global Drug Discovery Ecosystem5 Tips to Turn OpenAI Codex Into a Powerful AI Coding Agent
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ